These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Granzyme B May Act as an Effector Molecule to Control the Inflammatory Process in COPD. Kim WD; Sin DD COPD; 2024 Dec; 21(1):1-11. PubMed ID: 38314671 [TBL] [Abstract][Full Text] [Related]
23. Granzyme B in skin inflammation and disease. Turner CT; Lim D; Granville DJ Matrix Biol; 2019 Jan; 75-76():126-140. PubMed ID: 29247692 [TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinases in asthma and COPD. Demedts IK; Brusselle GG; Bracke KR; Vermaelen KY; Pauwels RA Curr Opin Pharmacol; 2005 Jun; 5(3):257-63. PubMed ID: 15907912 [TBL] [Abstract][Full Text] [Related]
26. Lung structure and function in COPD. Hogg JC Int J Tuberc Lung Dis; 2008 May; 12(5):467-79. PubMed ID: 18419881 [TBL] [Abstract][Full Text] [Related]
27. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. van Eeden SF; Sin DD Respiration; 2008; 75(2):224-38. PubMed ID: 18042978 [TBL] [Abstract][Full Text] [Related]
28. A mathematical model of protease-antiprotease homeostasis failure in chronic obstructive pulmonary disease (COPD). Cox LA Risk Anal; 2009 Apr; 29(4):576-86. PubMed ID: 19000077 [TBL] [Abstract][Full Text] [Related]
29. Role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Kanazawa H Med Sci Monit; 2007 Nov; 13(11):RA189-195. PubMed ID: 17968307 [TBL] [Abstract][Full Text] [Related]
30. Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD). MacNee W Biochem Soc Trans; 2009 Aug; 37(Pt 4):819-23. PubMed ID: 19614601 [TBL] [Abstract][Full Text] [Related]
31. Aspects on pathophysiological mechanisms in COPD. Larsson K J Intern Med; 2007 Sep; 262(3):311-40. PubMed ID: 17697154 [TBL] [Abstract][Full Text] [Related]
32. [The pathogenesis of chronic obstructive pulmonary disease, steroid resistance and the place of theophylline in the treatment]. Bayram H Tuberk Toraks; 2009; 57(1):115-24. PubMed ID: 19533448 [TBL] [Abstract][Full Text] [Related]
33. The missing link: chemokine receptors and tissue matrix breakdown in COPD. Smit JJ; Lukacs NW Trends Pharmacol Sci; 2006 Nov; 27(11):555-7. PubMed ID: 17000010 [TBL] [Abstract][Full Text] [Related]
38. The serine protease granzyme B as an inflammatory marker, in relation to the insulin receptor cleavage in human obesity and type 2 diabetes mellitus. El Mesallamy HO; Hamdy NM; Mostafa DM; Amin AI J Interferon Cytokine Res; 2014 Mar; 34(3):179-86. PubMed ID: 24195710 [TBL] [Abstract][Full Text] [Related]
39. Surfactant protein D: a lung specific biomarker in COPD? Sin DD; Pahlavan PS; Man SF Ther Adv Respir Dis; 2008 Apr; 2(2):65-74. PubMed ID: 19124360 [TBL] [Abstract][Full Text] [Related]
40. Senescence hypothesis for the pathogenetic mechanism of chronic obstructive pulmonary disease. Aoshiba K; Nagai A Proc Am Thorac Soc; 2009 Dec; 6(7):596-601. PubMed ID: 19934355 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]